Amedeo Smart

Free Medical Literature Service


 

Amedeo

Bladder Cancer

  Free Subscription

Articles published in
Cancer
    February 2024
  1. NIERENGARTEN MB
    Major advancements in first-line treatments for advanced urothelial cancer.
    Cancer. 2024;130:333-334.
    >> Share

    January 2024
  2. PEIPERT JD, Chang J, Li S, di Pietro A, et al
    Reliability, validity, and change thresholds of the NCCN/FACT Bladder Symptom Index (NFBlSI-18) in patients with advanced urothelial cancer.
    Cancer. 2024;130:31-40.
    >> Share

    December 2022
  3. HO MD, Modi PK
    Novel cryotherapy in non-muscle-invasive bladder cancer.
    Cancer. 2022 Dec 7. doi: 10.1002/cncr.34560.
    >> Share

  4. XU C, Jiang S, Zou L, Sheng L, et al
    Endoscopic balloon cryoablation plus transurethral resection for bladder cancer: A phase 2, multicenter, randomized, controlled trial.
    Cancer. 2022 Dec 7. doi: 10.1002/cncr.34563.
    >> Share

    October 2022
  5. DOERSCH KM, Tabayoyong WB, Bandari J
    Evaluation of toxicities for intravesical drugs in phase 1 bladder cancer trials.
    Cancer. 2022 Oct 19. doi: 10.1002/cncr.34508.
    >> Share

  6. JOYCE DD, Wymer KM, Sharma V, Moriarty JP, et al
    Comparative cost-effectiveness of neoadjuvant chemotherapy regimens for muscle-invasive bladder cancer: Results according to VESPER data.
    Cancer. 2022 Oct 17. doi: 10.1002/cncr.34502.
    >> Share

    August 2022
  7. MARTINI A, Yu M, Raggi D, Joshi H, et al
    Adjuvant immunotherapy in patients with high-risk muscle-invasive urothelial carcinoma: The potential impact of informative censoring.
    Cancer. 2022;128:2892-2897.
    >> Share

    March 2022
  8. KOSHKIN VS, Henderson N, James M, Natesan D, et al
    Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study.
    Cancer. 2022;128:1194-1205.
    >> Share

    September 2021
  9. SMITH AB, Lee JR, Lawrence SO, Lavallee DC, et al
    Patient and public involvement in the design and conduct of a large, pragmatic observational trial to investigate recurrent, high-risk non-muscle-invasive bladder cancer.
    Cancer. 2021 Sep 8. doi: 10.1002/cncr.33897.
    >> Share

    July 2021
  10. LAWLER C, Gu L, Howard LE, Branche B, et al
    The impact of the social construct of race on outcomes among bacille Calmette-Guerin-treated patients with high-risk non-muscle-invasive bladder cancer in an equal-access setting.
    Cancer. 2021 Jul 8. doi: 10.1002/cncr.33792.
    >> Share

    May 2021
  11. HAEUSER L, Marchese M, Schrag D, Trinh QD, et al
    The impact of smoking on radical cystectomy complications increases in elderly patients.
    Cancer. 2021;127:1387-1394.
    >> Share

    March 2021
  12. PRINTZ C
    Liquid biopsy test appears better at detecting bladder cancer than urine cytology.
    Cancer. 2021;127:663.
    >> Share

    January 2021
  13. LAUTZ TB, Chi YY, Li M, Wolden SL, et al
    Benefit of delayed primary excision in rhabdomyosarcoma: A report from the Children's Oncology Group.
    Cancer. 2021;127:275-283.
    >> Share

    November 2020
  14. GARG T, McMullen CK, Leo MC, O'Keeffe-Rosetti MC, et al
    Predicting risk of multiple levels of recurrence and progression after initial diagnosis of nonmuscle-invasive bladder cancer in a multisite, community-based cohort.
    Cancer. 2020 Nov 4. doi: 10.1002/cncr.33300.
    >> Share

    June 2020
  15. PAL SK, Bajorin D, Dizman N, Hoffman-Censits J, et al
    Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell-free DNA results.
    Cancer. 2020;126:2597-2606.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016